These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7677218)

  • 1. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.
    Ben Salah A; Zakraoui H; Zaatour A; Ftaiti A; Zaafouri B; Garraoui A; Olliaro PL; Dellagi K; Ben Ismail R
    Am J Trop Med Hyg; 1995 Aug; 53(2):162-6. PubMed ID: 7677218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.
    Asilian A; Jalayer T; Whitworth JA; Ghasemi RL; Nilforooshzadeh M; Olliaro P
    Am J Trop Med Hyg; 1995 Dec; 53(6):648-51. PubMed ID: 8561269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.
    Ben Salah A; Buffet PA; Morizot G; Ben Massoud N; Zâatour A; Ben Alaya N; Haj Hamida NB; El Ahmadi Z; Downs MT; Smith PL; Dellagi K; Grögl M
    PLoS Negl Trop Dis; 2009; 3(5):e432. PubMed ID: 19415122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.
    Iraji F; Sadeghinia A
    Ann Trop Med Parasitol; 2005 Jan; 99(1):3-9. PubMed ID: 15701249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
    Arana BA; Mendoza CE; Rizzo NR; Kroeger A
    Am J Trop Med Hyg; 2001 Nov; 65(5):466-70. PubMed ID: 11716099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
    el-On J; Halevy S; Grunwald MH; Weinrauch L
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):227-31. PubMed ID: 1430361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.
    Asilian A; Jalayer T; Nilforooshzadeh M; Ghassemi RL; Peto R; Wayling S; Olliaro P; Modabber F
    Bull World Health Organ; 2003; 81(5):353-9. PubMed ID: 12856053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical paromomycin for New World cutaneous leishmaniasis.
    Sosa N; Pascale JM; Jiménez AI; Norwood JA; Kreishman-Detrick M; Weina PJ; Lawrence K; McCarthy WF; Adams RC; Scott C; Ransom J; Tang D; Grogl M
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007253. PubMed ID: 31048871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
    Ben Salah A; Ben Messaoud N; Guedri E; Zaatour A; Ben Alaya N; Bettaieb J; Gharbi A; Belhadj Hamida N; Boukthir A; Chlif S; Abdelhamid K; El Ahmadi Z; Louzir H; Mokni M; Morizot G; Buffet P; Smith PL; Kopydlowski KM; Kreishman-Deitrick M; Smith KS; Nielsen CJ; Ullman DR; Norwood JA; Thorne GD; McCarthy WF; Adams RC; Rice RM; Tang D; Berman J; Ransom J; Magill AJ; Grogl M
    N Engl J Med; 2013 Feb; 368(6):524-32. PubMed ID: 23388004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.
    Ozgoztasi O; Baydar I
    Int J Dermatol; 1997 Jan; 36(1):61-3. PubMed ID: 9071622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
    Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of paromomycin sulphate topical ointment as effective therapeutic agent in cutaneous leishmaniasis.
    Sahibzada NJ; Tareen AK; Khursheed T; Darr N
    J Pak Med Assoc; 1996 Mar; 46(3):53-5. PubMed ID: 8991348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG; Silva DL; Nunan FA; Nunan EA; Fernandes AP; Ferreira LA
    J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B; Abbaszadeh B; Khamesipour A
    Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z; Nakhli A; Rassaii S
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous Leishmaniasis in an American Adolescent Returning From Israel.
    Ganjaei KG; Lawton K; Gaur S
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):e178-e181. PubMed ID: 29878238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
    El-On J; Bazarsky E; Sneir R
    Exp Parasitol; 2007 Jun; 116(2):156-62. PubMed ID: 17306255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.
    Neal RA; Murphy AG; Olliaro P; Croft SL
    Trans R Soc Trop Med Hyg; 1994; 88(2):223-5. PubMed ID: 8036682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.
    Neva FA; Ponce C; Ponce E; Kreutzer R; Modabber F; Olliaro P
    Trans R Soc Trop Med Hyg; 1997; 91(4):473-5. PubMed ID: 9373659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment.
    el-Safi SH; Murphy AG; Bryceson AD; Neal RA
    Trans R Soc Trop Med Hyg; 1990; 84(5):690-1. PubMed ID: 2278070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.